ATE377588T1 - Zwischenprodukt für die herstellung von pioglitazon - Google Patents
Zwischenprodukt für die herstellung von pioglitazonInfo
- Publication number
- ATE377588T1 ATE377588T1 AT04731028T AT04731028T ATE377588T1 AT E377588 T1 ATE377588 T1 AT E377588T1 AT 04731028 T AT04731028 T AT 04731028T AT 04731028 T AT04731028 T AT 04731028T AT E377588 T1 ATE377588 T1 AT E377588T1
- Authority
- AT
- Austria
- Prior art keywords
- pioglitazone
- production
- intermediate product
- product
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/55—Acids; Esters
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES200301075A ES2219180B1 (es) | 2003-05-09 | 2003-05-09 | Compuesto intermedio util para la preparacion de pioglitazona. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE377588T1 true ATE377588T1 (de) | 2007-11-15 |
Family
ID=33427384
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT04731028T ATE377588T1 (de) | 2003-05-09 | 2004-05-04 | Zwischenprodukt für die herstellung von pioglitazon |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US7375231B2 (de) |
| EP (1) | EP1623977B1 (de) |
| AR (1) | AR044267A1 (de) |
| AT (1) | ATE377588T1 (de) |
| CA (1) | CA2525190A1 (de) |
| DE (1) | DE602004009917T2 (de) |
| ES (2) | ES2219180B1 (de) |
| PL (1) | PL1623977T3 (de) |
| PT (1) | PT1623977E (de) |
| WO (1) | WO2004099147A1 (de) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090111828A1 (en) * | 2005-11-23 | 2009-04-30 | Astrazeneca Ab | L-alanine derivatives |
| WO2008093065A1 (en) * | 2007-01-29 | 2008-08-07 | Astrazeneca Ab | L-ALANINE DERIVATIVES AS α5βL ANTAGONISTS |
| WO2008125811A1 (en) * | 2007-04-11 | 2008-10-23 | Astrazeneca Ab | N-[HETEROARYLCARBONYL]-S-THIENYL-L-ALANINE DERIVATIVES AS α5β1 ANTAGONISTS |
| WO2012177956A1 (en) * | 2011-06-23 | 2012-12-27 | Metabolic Solutions Development Comapny, Llc | Ppar-sparing compounds for use in the treatment of diabetes and other metabolic diseases |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR240698A1 (es) * | 1985-01-19 | 1990-09-28 | Takeda Chemical Industries Ltd | Procedimiento para preparar compuestos de 5-(4-(2-(5-etil-2-piridil)-etoxi)benzil)-2,4-tiazolidindiona y sus sales |
| JPH08325263A (ja) * | 1995-05-31 | 1996-12-10 | Sumitomo Metal Ind Ltd | 新規２−アミノ−３−フェニルプロピオン酸誘導体 |
| JP2000344748A (ja) * | 1999-03-29 | 2000-12-12 | Welfide Corp | ３−芳香族置換プロピオン酸またはアクリル酸化合物 |
| ATE355286T1 (de) * | 2001-04-26 | 2006-03-15 | Zentiva As | Verfahren zur herstellung von pioglitazone als antidiabetisches mitttel |
-
2003
- 2003-05-09 ES ES200301075A patent/ES2219180B1/es not_active Expired - Fee Related
-
2004
- 2004-05-04 CA CA002525190A patent/CA2525190A1/en not_active Abandoned
- 2004-05-04 EP EP04731028A patent/EP1623977B1/de not_active Expired - Lifetime
- 2004-05-04 PT PT04731028T patent/PT1623977E/pt unknown
- 2004-05-04 ES ES04731028T patent/ES2297415T3/es not_active Expired - Lifetime
- 2004-05-04 PL PL04731028T patent/PL1623977T3/pl unknown
- 2004-05-04 AT AT04731028T patent/ATE377588T1/de not_active IP Right Cessation
- 2004-05-04 WO PCT/ES2004/070031 patent/WO2004099147A1/es active IP Right Grant
- 2004-05-04 US US10/555,659 patent/US7375231B2/en not_active Expired - Fee Related
- 2004-05-04 DE DE602004009917T patent/DE602004009917T2/de not_active Expired - Fee Related
- 2004-05-07 AR ARP040101563A patent/AR044267A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PT1623977E (pt) | 2008-01-22 |
| PL1623977T3 (pl) | 2008-04-30 |
| DE602004009917T2 (de) | 2008-08-21 |
| DE602004009917D1 (de) | 2007-12-20 |
| US20070083050A1 (en) | 2007-04-12 |
| US7375231B2 (en) | 2008-05-20 |
| EP1623977B1 (de) | 2007-11-07 |
| ES2219180B1 (es) | 2006-03-01 |
| AR044267A1 (es) | 2005-09-07 |
| WO2004099147A1 (es) | 2004-11-18 |
| CA2525190A1 (en) | 2004-11-18 |
| ES2297415T3 (es) | 2008-05-01 |
| EP1623977A1 (de) | 2006-02-08 |
| ES2219180A1 (es) | 2004-11-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE447564T1 (de) | Zwischenprodukte für die herstellung von trans-5- chlor-2-methyl-2,3,3a,12b-tetrahydro-1h-dibenzä , 3:6,7üoxepinoä4,5-cüpyrrol | |
| ATE434598T1 (de) | Zwischenprodukte für die herstellung von dioxan-2-alkylcarbamaten | |
| DE50110695D1 (de) | Anlage für die Herstellung von Druckprodukten | |
| DE602004000740D1 (de) | Herstellung von Nuten | |
| NO20053796D0 (no) | Process for the production of particles | |
| NO20043345L (no) | Fremgangsmate for fremstilling av hydrokarboner | |
| DE602006014558D1 (de) | Verbessertes verfahren für die herstellung von tee | |
| PL2322511T3 (pl) | Sposób wytwarzania telmisartanu | |
| BR0313226B1 (pt) | processo para produÇço de produto de fermentaÇço. | |
| IS2674B (is) | Aðferð við framleiðslu á handhverfulega hreinu mírtasapíni | |
| ATE441745T1 (de) | Polypropylenfasern für die herstellung von thermisch verfestigten spinnvliesen | |
| NO20053205D0 (no) | Forbedret fremgangsmate for produksjon av vitamin B12. | |
| FI20041665A0 (fi) | Menetelmä kuitutuotteiden valmistamiseksi | |
| SE0301552L (sv) | New product | |
| HK1088334A1 (en) | Process for the production of bis(trimethylsiloxy)silylalkylglycerol methacrylates | |
| DE60323456D1 (de) | Herstellung von Nanopartikeln | |
| ITBO20030349A1 (it) | Procedimento e macchina per la produzione di scatole di | |
| ATE377588T1 (de) | Zwischenprodukt für die herstellung von pioglitazon | |
| DE60238030D1 (de) | Katalysatorzusammensetzung für die Herstellung von Polyolefinen | |
| DE602004004777D1 (de) | Kontinuierliches verfahren für die herstellung von polyamiden | |
| GB0312966D0 (en) | Process for the production of olefins | |
| DE602004008092D1 (de) | Pressblasmaschine für die herstellung von hohlen glaswaren | |
| ATE401299T1 (de) | Verfahren für die herstellung von hydroxyethylaminen | |
| ITMI20030346A1 (it) | Procedimento per la produzione di mesitilene. | |
| DE60224968D1 (de) | Prozess für die Herstellung von 5-Arylpentanolen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |